Cargando…

Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667593/ https://www.ncbi.nlm.nih.gov/pubmed/33204093 http://dx.doi.org/10.2147/IJN.S289131

Ejemplares similares

Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response
por: Yin, Peidi, et al.
Publicado: (2020)

In situ Delivery of Thermosensitive Gel-Mediated 5-Fluorouracil Microemulsion for the Treatment of Colorectal Cancer [Corrigendum]
Publicado: (2020)

Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
por: Islam, Salman Ul, et al.
Publicado: (2020)

Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model [Corrigendum]
Publicado: (2023)

Corrigendum to: Drying banana seeds for ex situ conservation
por: Kallow, Simon, et al.
Publicado: (2022)

Corrigendum to “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”
por: Cheng, Ling-Gang, et al.
Publicado: (2017)

CIRP Regulates BEV-Induced Cell Migration in Gliomas [Corrigendum]
Publicado: (2020)

Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021)

Validation of second trimester miscarriages and spontaneous deliveries [Corrigendum]
Publicado: (2017)

Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
Publicado: (2023)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

Corrigendum to “An In Situ Evaluation of the Protective Effect of Nano Eggshell/Titanium Dioxide against Erosive Acids”
por: Onwubu, Stanley Chibuzor, et al.
Publicado: (2019)

Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum]
Publicado: (2021)

Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm [Corrigendum]
Publicado: (2013)

Corrigendum to “Simulating Radiotherapy Effect in High-Grade Glioma by Using Diffusive Modeling and Brain Atlases”
por: Roniotis, Alexandros, et al.
Publicado: (2018)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023)

Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum]
Publicado: (2021)

Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
Publicado: (2019)

Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]
Publicado: (2020)

Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer [Corrigendum]
Publicado: (2017)

Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle [Corrigendum]
Publicado: (2018)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Publicado: (2021)

Intrathecal Drug Delivery Systems Survey: Trends in Utilization in Pain Practice [Corrigendum]
Publicado: (2023)

Corrigendum to: Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas
Publicado: (2023)

40 years of Alma Ata Malaysia: Targeting equitable access through organisational and physical adaptations in the delivery of public sector primary care – CORRIGENDUM
por: Fadzil, Fariza, et al.
Publicado: (2020)

Inhibition of Proliferation and Migration of Tumor Cells Through Phenylboronic Acid-Functionalized Polyamidoamine-Mediated Delivery of a Therapeutic DNAzyme Dz13 [Corrigendum]
Publicado: (2021)

Dengue infections in non-immune travellers to Thailand – CORRIGENDUM
por: MASSAD, E., et al.
Publicado: (2013)

Corrigendum: Fluid responsiveness in the pediatric population
por: Lee, Ji-Hyun, et al.
Publicado: (2019)

Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum]
Publicado: (2022)

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Corrigendum]
Publicado: (2021)

A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]
Publicado: (2022)

Corrigendum to “Subchronic Infection of Porphyromonas gingivalis and Tannerella forsythia Stimulates an Immune Response but Not Arthritis in Experimental Murine Model”
por: Hernández-Aguas, Jorday, et al.
Publicado: (2018)

Corrigendum to “Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population”
por: Li, Jiwei, et al.
Publicado: (2022)

Corrigendum to: Intestinal and enthesis innate immunity in early axial spondyloarthropathy
por: Sharif, Kassem, et al.
Publicado: (2020)

On Carlsbad Treatment for Anglo-Indians: Corrigendum
Publicado: (1891)

Corrigendum to “Supporting the dying is a community responsibility”
Publicado: (2022)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Publicado: (2020)

Corrigendum to “Inadequate Prenatal Visit and Home Delivery as Determinants of Perinatal Outcomes: Does Parity Matter?”
por: Bililign Yimer, Nigus, et al.
Publicado: (2019)

Silver Nanoparticles as Chlorhexidine and Metronidazole Drug Delivery Platforms: Their Potential Use in Treating Periodontitis [Corrigendum]
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hhcrd5sk5i2pre91vgrs7oaem3